Prostate-specific membrane antigen-specific antitumor activity of a self-immolative tubulysin conjugate

CP Leamon, JA Reddy, A Bloomfield… - Bioconjugate …, 2019 - ACS Publications
Prostate-specific membrane antigen (PSMA) is a biomarker that is overexpressed on
prostate cancer, and it is also present on the neovasculature within many non-prostate solid …

PSMA binding ligand-linker conjugates and methods for using

PS Low, SA Kularatne - US Patent 10,046,054, 2018 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …

PSMA binding ligand-linker conjugates and methods for using

PS Low, V Chelvam, Y Kim, SA Kularatne - US Patent 9,951,324, 2018 - Google Patents
4, 691, 024 A 9/1987 Kunikatsu et al. 4, 713, 249 A 12/1987 Schroder 5, 103, 018 A 4/1992
Motomichi et al. 5, 266, 333 A 11/1993 Cady et al. 5, 418, 982 A 5/1995 Kishi 5, 627, 165 A …

PSMA binding ligand-linker conjugates and methods for using

PS Low, SA Kularatne - US Patent 10,624,970, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …

PSMA binding ligand-linker conjugates and methods for using

PS Low, SA Kularatne - US Patent 10,517,956, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …

Insights Into the Synthetic Strategies, Biological Activity, and Structure-Activity Relationship of Pyridine and Analogs: A Review

A Matthew, R Kumar, A Mazumder… - Letters in Organic …, 2023 - benthamdirect.com
Based on various research reports, pyridine possesses a wide range of pharmacological
activities along with many other industrial applications. Because of its diverse applications …

PSMA binding ligand-linker conjugates and methods for using

PS Low, SA Kularatne - US Patent 10,624,971, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …

PSMA binding ligand-linker conjugates and methods for using

PS Low, SA Kularatne - US Patent 10,646,581, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …

PSMA binding ligand-linker conjugates and methods for using

PS Low, SA Kularatne - US Patent 10,485,878, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …

PSMA binding ligand-linker conjugates and methods for using

PS Low, SA Kularatne - US Patent 10,624,969, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …